These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2065167)
1. An image analysis on MR imaging of the brain for hepatic encephalopathy. Syh HW; Chu WK; Mar N; McConnell JR Biomed Sci Instrum; 1991; 27():29-33. PubMed ID: 2065167 [TBL] [Abstract][Full Text] [Related]
2. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484 [TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MR of the brain: methodology and clinical application. Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887 [TBL] [Abstract][Full Text] [Related]
4. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping]. Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785 [TBL] [Abstract][Full Text] [Related]
5. Automatic identification of gray matter structures from MRI to improve the segmentation of white matter lesions. Warfield S; Dengler J; Zaers J; Guttmann CR; Wells WM; Ettinger GJ; Hiller J; Kikinis R J Image Guid Surg; 1995; 1(6):326-38. PubMed ID: 9080353 [TBL] [Abstract][Full Text] [Related]
7. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263 [TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of magnetic resonance imaging (MRI) abnormalities in subclinical hepatic encephalopathy. Solomou E; Velissaris D; Polychronopoulos P; Kalogeropoulos A; Kiriakopoulou M; Mpadra F; Kordonouri T; Karantza Ch Hepatogastroenterology; 2005; 52(61):203-7. PubMed ID: 15783031 [TBL] [Abstract][Full Text] [Related]
9. [Cranial MRI in hepatic disease--relationship between MR imaging and clinical symptoms and laboratory analysis of liver function]. Iijima M; Kamitani T; Kamakura K; Nagata N; Tsuchiya K Rinsho Shinkeigaku; 1993 Oct; 33(10):1047-54. PubMed ID: 8293604 [TBL] [Abstract][Full Text] [Related]
10. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Shah NJ; Neeb H; Zaitsev M; Steinhoff S; Kircheis G; Amunts K; Häussinger D; Zilles K Hepatology; 2003 Nov; 38(5):1219-26. PubMed ID: 14578860 [TBL] [Abstract][Full Text] [Related]
11. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. Lee SS; Byun JH; Hong HS; Park SH; Won HJ; Shin YM; Lee MG J Magn Reson Imaging; 2007 Aug; 26(2):323-30. PubMed ID: 17610287 [TBL] [Abstract][Full Text] [Related]
12. [Diffusion weighted MR: principles and clinical use in selected brain diseases]. Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509 [TBL] [Abstract][Full Text] [Related]
13. [Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy]. Schneider JP; Krohmer S; Günther A; Zimmer C Rofo; 2006 Jun; 178(6):618-26. PubMed ID: 16703498 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Gupta RK; Saraswat VA; Poptani H; Dhiman RK; Kohli A; Gujral RB; Naik SR Am J Gastroenterol; 1993 May; 88(5):670-4. PubMed ID: 8480729 [TBL] [Abstract][Full Text] [Related]
15. Quantitative cerebral water content mapping in hepatic encephalopathy. Shah NJ; Neeb H; Kircheis G; Engels P; Häussinger D; Zilles K Neuroimage; 2008 Jul; 41(3):706-17. PubMed ID: 18456518 [TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance imaging (MRI) findings of temporal lobe radiation encephalopathy]. Zhao JQ; Liang BL; Shen J; Sun Y Ai Zheng; 2003 Nov; 22(11):1209-13. PubMed ID: 14613655 [TBL] [Abstract][Full Text] [Related]
17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance imaging findings of postresuscitation encephalopathy: sequential change and correlation with clinical outcome]. Goto Y; Wataya T; Arakawa Y; Hojo M; Chin M; Yamagata S; Kikuta K; Ishii A No To Shinkei; 2001 Jun; 53(6):535-40. PubMed ID: 11436337 [TBL] [Abstract][Full Text] [Related]
19. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867 [TBL] [Abstract][Full Text] [Related]
20. Automated separation of gray and white matter from MR images of the human brain. Schnack HG; Hulshoff Pol HE ; Baaré WF; Staal WG; Viergever MA; Kahn RS Neuroimage; 2001 Jan; 13(1):230-7. PubMed ID: 11133325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]